Goodwin Advises TELA on $46 Million Underwritten Public Offering of Common Stock
October 28, 2024
October 28, 2024
BOSTON, Massachusetts, Oct. 28 -- Goodwin, a law firm, issued the following news release:
The Goodwin Life Science team advised TELA Bio, Inc. ("TELA") on an underwritten public offering of 14,670,000 shares of its common stock, including the exercise in full of the underwriters' option to purchase additional shares, at a price to the public of $2.25 per share and pre-funded warrants to purchase 5,800,000 shares of common stock at a public offering price of $2.2499 per pre . . .
The Goodwin Life Science team advised TELA Bio, Inc. ("TELA") on an underwritten public offering of 14,670,000 shares of its common stock, including the exercise in full of the underwriters' option to purchase additional shares, at a price to the public of $2.25 per share and pre-funded warrants to purchase 5,800,000 shares of common stock at a public offering price of $2.2499 per pre . . .